Stories

Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.

Discovery

Mutant protein spreads through a neural circuit in Huntington’s Disease

Discovery

Novartis Institutes for BioMedical Research

Jul 15, 2021

Mutant protein spreads through a neural circuit in Huntington’s Disease

Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.

Discovery

Discovery

Novartis Institutes for BioMedical ResearchTargeted Therapy

Jul 13, 2021

Cancer cocktails come of age

Novartis teams test combinations of targeted therapeutic agents to combat drug resistance in tumors.

Discovery

Cancer cocktails: LJM716 – closing a common release valve

Discovery

Novartis Institutes for BioMedical Research

Jul 13, 2021

Combination therapies: Seeking to block cancer’s pathways to growth

Talk to any cancer researcher or doctor today and what you hear is wonder and hope.

Discovery

Novartis antibody increases muscle growth in mice and human cell cultures

Discovery

Novartis Institutes for BioMedical Research

Jul 20, 2021

Novartis antibody increases muscle growth in mice and human cell cultures

An antibody that boosts muscle mass could mean independence for the frail and elderly. Learn how Novartis research aims to improve healthy aging.

Discovery

Discovery

Children's HealthGene SequencingInnovationNeurodegenerative DiseaseRare Diseases

Jul 22, 2021

Tackling a rare disease: Working toward a treatment for SMA

Most people have never heard of spinal muscular atrophy (SMA), a rare genetic disease that affects approximately 1 in 6,000 babies born worldwide each year. Innovative research may produce treatments for patients suffering from SMA and other rare diseases.

Discovery